Keng-Fu Hsu (Keng Fu Hsu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Endometrial Cancer

Top Venues

Journal of biomedical science

International journal of molecular sciences

NCKU (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

NCKU

Taiwan

PHD :: OBS GYN

Publications

Chang-Ni Lin, Yu-Ling Liang, Hsing-Fen Tsai, Pei-Ying Wu, Lan-Yin Huang, Yu-Han Lin, Chieh-Yi Kang, Chao-Ling Yao, Meng-Ru Shen, Keng-Fu Hsu
Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. Journal of biomedical science 31 (1) (2024)
Chia-Jung Chiang, Wei-Lun Hsu, Mei-Tsz Su, Wen-Chien Ko, Keng-Fu Hsu, Pei-Yin Tsai
Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency. Vaccines 12 (2) (2024)
Chia-Jung Chiang, Wei-Lun Hsu, Mei-Tsz Su, Wen-Chien Ko, Keng-Fu Hsu, Pei-Yin Tsai
Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency. Vaccines 12 (2) (2024)
Chang-Ni Lin, Yu-Ling Liang, Hsing-Fen Tsai, Pei-Ying Wu, Lan-Yin Huang, Yu-Han Lin, Chieh-Yi Kang, Chao-Ling Yao, Meng-Ru Shen, Keng-Fu Hsu
Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. Journal of biomedical science 31 (1) (2024)
Chang-Ni Lin, Yu-Ling Liang, Hsing-Fen Tsai, Pei-Ying Wu, Lan-Yin Huang, Yu-Han Lin, Chieh-Yi Kang, Chao-Ling Yao, Meng-Ru Shen, Keng-Fu Hsu
Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. Journal of biomedical science 31 (1) (2024)
Hsing-Fen Tsai, Ching-Fen Tseng, Yu-Ling Liang, Pei-Ying Wu, Lan-Yin Huang, Yu-Han Lin, Li-Hsuan Lin, Chang-Ni Lin, Keng-Fu Hsu
Downregulation of Salt-Inducible Kinase 3 Enhances CCL24 Activation in the Placental Environment with Preeclampsia. International journal of molecular sciences 25 (1) (2023)
Hsing-Fen Tsai, Ching-Fen Tseng, Yu-Ling Liang, Pei-Ying Wu, Lan-Yin Huang, Yu-Han Lin, Li-Hsuan Lin, Chang-Ni Lin, Keng-Fu Hsu
Downregulation of Salt-Inducible Kinase 3 Enhances CCL24 Activation in the Placental Environment with Preeclampsia. International journal of molecular sciences 25 (1) (2023)
Hsing-Fen Tsai, Ching-Fen Tseng, Yu-Ling Liang, Pei-Ying Wu, Lan-Yin Huang, Yu-Han Lin, Li-Hsuan Lin, Chang-Ni Lin, Keng-Fu Hsu
Downregulation of Salt-Inducible Kinase 3 Enhances CCL24 Activation in the Placental Environment with Preeclampsia. International journal of molecular sciences 25 (1) (2023)
Peng-Chan Lin, Yu-Min Yeh, Hui-Ping Hsu, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, Keng-Fu Hsu, Jenn-Ren Hsiao, Yan-Shen Shan, Meng-Ru Shen
Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers. Cancers 13 (17) (2021)
Yu-Ling Liang, Chang-Ni Lin, Hsing-Fen Tsai, Pei-Ying Wu, Sheng-Hsiang Lin, Tse-Ming Hong, Keng-Fu Hsu
Omental Macrophagic "Crown-like Structures" Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer. Current oncology (Toronto, Ont.) 28 (5) (2021)
Yu-Min Yeh, Pei-Ying Wu, Peng-Chan Lin, Pei-Fang Su, Ya-Ting Hsu, Keng-Fu Hsu, Meng-Ru Shen
MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer. Cancers 13 (16) (2021)
Han-Wei Huang, Pei-Ying Wu, Pei-Fang Su, Chung-I Li, Yu-Min Yeh, Peng-Chan Lin, Keng-Fu Hsu, Meng-Ru Shen, Jang-Yang Chang, Chou-Ching K Lin
A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy. Disease markers 2020 (2020)
Peng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, Keng-Fu Hsu, Jang-Yang Chang, Meng-Ru Shen
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer. Scientific reports 10 (1) (2020)
Wei-Ting Liu, Wen-Bin Lee, Yi-Cheng Tsai, Yuan-Jhe Chuang, Keng-Fu Hsu, Gwo-Bin Lee
An automated microfluidic system for selection of aptamer probes against ovarian cancer tissues. Biomicrofluidics 13 (1) (2019)
Peng-Chan Lin, Yu-Min Yeh, Pei-Ying Wu, Keng-Fu Hsu, Jang-Yang Chang, Meng-Ru Shen
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer. Scientific reports 9 (1) (2019)
Hung-Chun Fu, Jen Ruei Chen, Min Yu Chen, Keng-Fu Hsu, Wen-Fang Cheng, An Jen Chiang, Yu Min Ke, Yu Chieh Chen, Yin Yi Chang, Chia Yen Huang, Chieh Yi Kang, Yuan Yee Kan, Sheng Mou Hsiao, Ming Shyen Yen
Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study. Journal of gynecologic oncology 29 (5) (2018)
Ming-Shyen Yen, Tze-Ho Chen, Yu-Min Ke, Keng-Fu Hsu, Jen-Ruei Chen, Mu-Hsien Yu, Hung-Chun Fu, Chia-Yen Huang, An-Jen Chiang, Chao-Yu Chen, Sheng-Mou Hsiao, Yuen-Yee Kan, Fu-Shing Liu
Clinicopathologic Features and Treatment Outcomes in Patients with Stage I, High-Risk Histology or High-Grade Endometrial Cancer after Primary Staging Surgery: A Taiwanese Gynecologic Oncology Group Study. Journal of clinical medicine 7 (9) (2018)
Lien-Yu Hung, Chien-Yu Fu, Chih-Hung Wang, Yuan-Jhe Chuang, Yi-Cheng Tsai, Yi-Ling Lo, Pang-Hung Hsu, Hwan-You Chang, Shu-Chu Shiesh, Keng-Fu Hsu, Gwo-Bin Lee
Microfluidic platforms for rapid screening of cancer affinity reagents by using tissue samples. Biomicrofluidics 12 (5) (2018)